03 Apr Rest is Not Always Best: New Research on the Treatment of Concussion & Traumatic Brain Injury
2450 W North Ave
Milwaukee, WI 53205
You are invited to a brief presentation by expert on brain injury, Dr. Lindsay Nelson, followed by a conversation with community members.
What you’ll discover during the session
- The discussion will shed light on how to recognize traumatic brain injury (TBI) and when to seek help
- New knowledge about how much to rest (versus be active) after concussions
- Why prior attempts to find treatments for severe TBI have not been successful
- Ongoing research to develop better treatments for TBI
Dinner will be served.
This discussion will be led by Lindsay Nelson, PhD, Assistant Professor, Neurosurgery and Neurology, Medical College of Wisconsin.
About the session leader
Dr. Nelson is an assistant professor and board-certified clinical neuropsychologist at the Medical College of Wisconsin. She has a broad background in clinical psychology and traumatic brain injury.
Since joining the Medical College of Wisconsin in 2012, Dr. Nelson has worked in the Center for Neurotrauma Research where she conducts studies of mild traumatic brain injury (mTBI). Her overall goal in this research is to advance our understanding of the psychosocial, cognitive, and neurobiological sequelae of mTBI to improve its diagnosis, assessment, and treatment.
Her work has been particularly geared toward prediction of individual differences in recovery from mTBI, study of the interplay between various neurobiopsychosocial factors as they pertain to mTBI diagnosis and recovery, and evaluation of the reliability and validity of clinical assessment tools for diagnosing and monitoring mTBI.
Dr. Nelson has led a number of internally and externally funded studies and serves as a co-investigator on large prospective studies of both sport and civilian/community TBI. The aim of her primary research program is to leverage advance quantitative approaches to improve patient classification and outcome measurement for TBI, with a goal of facilitating the conduct of high-quality clinical trials that lead to the validation of new treatments for patients with TBI.